NPPA computed the Retail Price of Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Associated Biopharma Private Limited (Manufacturer) & M/s German Remedies Pharmaceuticals Private Limited. (Marketer)

Apr 09, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on April 06, 2026, issued the Computation of Retail Price of Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Associated Biopharma Private Limited (Manufacturer) & M/s German Remedies Pharmaceuticals Private Limited. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from July 2025

• The Retail Price has been computed for Each Film Coated Tablet Containing Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Associated Biopharma Private Limited (Manufacturer) & M/s German Remedies Pharmaceuticals Private Limited. (Marketer)

• The Total MAT is 2,75,36,38,217

[Notification No. 19(5051)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT